|
1
|
Bruix J and Llovet JM: Major achievements
in hepatocellular carcinoma. Lancet. 373:614–616. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Iiizumi M, Liu W, Pai SK, Furuta E and
Watabe K: Drug development against metastasis-related genes and
their pathways: A rationale for cancer therapy. Biochim Biophys
Acta. 1786:87–104. 2008.PubMed/NCBI
|
|
3
|
Forner A, Reig ME, de Lope CR and Bruix J:
Current strategy for staging and treatment: the BCLC update and
future prospects. Semin Liver Dis. 30:61–74. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Llovet JM, Fuster J and Bruix J;
Barcelona-Clínic Liver Cancer Group. The Barcelona approach:
diagnosis, staging, and treatment of hepatocellular carcinoma.
Liver Transpl. 10(2 Suppl 1): S115–S120. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yeh CN, Chen MF, Lee WC and Jeng LB:
Prognostic factors of hepatic resection for hepatocellular
carcinoma with cirrhosis: univariate and multivariate analysis. J
Surg Oncol. 81:195–202. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hanazaki K, Kajikawa S, Koide N, Adachi W
and Amano J: Prognostic factors after hepatic resection for
hepatocellular carcinoma with hepatitis C viral infection:
univariate and multivariate analysis. Am J Gastroenterol.
96:1243–1250. 2001. View Article : Google Scholar
|
|
7
|
Tsai T, Chau GY, Lui WY, Tsay SH, King KL,
Loong CC, Hsia CY and Wu CW: Clinical significance of microscopic
tumor venous invasion in patients with resectable hepatocellular
carcinoma. Surgery. 127:603–608. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Imamura H, Matsuyama Y, Tanaka E, et al:
Risk factors contributing to early and late phase intrahepatic
recurrence of hepatocellular carcinoma after hepatectomy. J
Hepatol. 38:200–207. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou D, Salnikow K and Costa M: Cap43, a
novel gene specifically induced by Ni2+ compounds. Cancer Res.
58:2182–2189. 1998.PubMed/NCBI
|
|
10
|
Kokame K, Kato H and Miyata T:
Homocysteine-respondent genes in vascular endothelial cells
identified by differential display analysis. GRP78/BiP and novel
genes. J Biol Chem. 271:29659–29665. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Akiba J, Ogasawara S, Kawahara A, et al:
N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal
vein invasion and intrahepatic metastasis in human hepatocellular
carcinoma. Oncol Rep. 20:1329–1335. 2008.PubMed/NCBI
|
|
12
|
Chua MS, Sun H, Cheung ST, et al:
Overexpression of NDRG1 is an indicator of poor prognosis in
hepatocellular carcinoma. Mod Pathol. 20:76–83. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cheng J, Xie HY, Xu X, et al: NDRG1 as a
biomarker for metastasis, recurrence and of poor prognosis in
hepatocellular carcinoma. Cancer Lett. 310:35–45. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guan RJ, Ford HL, Fu Y, Li Y, Shaw LM and
Pardee AB: Drg-1 as a differentiation-related, putative metastatic
suppressor gene in human colon cancer. Cancer Res. 60:749–755.
2000.PubMed/NCBI
|
|
15
|
Strzelczyk B, Szulc A, Rzepko R, et al:
Identification of high-risk stage II colorectal tumors by combined
analysis of the NDRG1 gene expression and the depth of tumor
invasion. Ann Surg Oncol. 16:1287–1294. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Maruyama Y, Ono M, Kawahara A, et al:
Tumor growth suppression in pancreatic cancer by a putative
metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of
angiogenesis. Cancer Res. 66:6233–6242. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song Y, Oda Y, Hori M, et al: N-myc
downstream regulated gene-1/Cap43 may play an important role in
malignant progression of prostate cancer, in its close association
with E-cadherin. Hum Pathol. 41:214–222. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sibold S, Roh V, Keogh A, et al: Hypoxia
increases cytoplasmic expression of NDRG1, but is insufficient for
its membrane localization in human hepatocellular carcinoma. FEBS
Lett. 581:989–994. 2007. View Article : Google Scholar
|
|
19
|
Budhu A, Forgues M, Ye Q-H, et al:
Prediction of venous metastases, recurrence, and prognosis in
hepatocellular carcinoma based on a unique immune response
signature of the liver microenvironment. Cancer Cell. 10:99–111.
2006. View Article : Google Scholar
|
|
20
|
Kurdistani SK, Arizti P, Reimer CL, Sugrue
MM, Aaronson SA and Lee SW: Inhibition of tumor cell growth by
RTP/rit42 and its responsiveness to p53 and DNA damage. Cancer Res.
58:4439–4444. 1998.PubMed/NCBI
|
|
21
|
Akiba J, Murakami Y, Noda M, et al: N-myc
downstream regulated gene1/Cap43 overexpression suppresses tumor
growth by hepatic cancer cells through cell cycle arrest at the
G0/G1 phase. Cancer Lett. 310:25–34. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
McCaig C, Potter L, Abramczyk O and Murray
JT: Phosphorylation of NDRG1 is temporally and spatially controlled
during the cell cycle. Biochem Biophys Res Commun. 411:227–234.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Taketomi Y, Sugiki T, Saito T, et al:
Identification of NDRG1 as an early inducible gene during in vitro
maturation of cultured mast cells. Biochem Biophys Res Commun.
306:339–346. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Piquemal D, Joulia D, Balaguer P, Basset
A, Marti J and Commes T: Differential expression of the
RTP/Drg1/Ndr1 gene product in proliferating and growth arrested
cells. Biochim Biophys Acta. 1450:364–373. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Angst E, Sibold S, Tiffon C, et al:
Cellular differentiation determines the expression of the
hypoxia-inducible protein NDRG1 in pancreatic cancer. Br J Cancer.
95:307–313. 2006. View Article : Google Scholar
|
|
26
|
Mao XY, Fan CF, Wei J, et al: Increased
N-myc downstream-regulated gene 1 expression is associated with
breast atypia-to-carcinoma progression. Tumour Biol. 32:1271–1276.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fotovati A, Abu-Ali S, Kage M, Shirouzu K,
Yamana H and Kuwano M: N-myc downstream-regulated gene 1 (NDRG1) a
differentiation marker of human breast cancer. Pathol Oncol Res.
17:525–533. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yan X, Chua MS, Sun H and So S: N-Myc
down-regulated gene 1 mediates proliferation, invasion, and
apoptosis of hepatocellular carcinoma cells. Cancer Lett.
262:133–142. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ureshino H, Murakami Y, Watari K, et al:
N-myc downstream regulated gene 1 (NDRG1) promotes metastasis of
human scirrhous gastric cancer cells through epithelial mesenchymal
transition. PLoS One. 7:e413122012. View Article : Google Scholar
|
|
30
|
Chen Z, Zhang D, Yue F, Zheng M, Kovacevic
Z and Richardson DR: The iron chelators Dp44mT and DFO inhibit
TGF-beta-induced epithelial-mesenchymal transition via
up-regulation of N-Myc downstream-regulated gene 1 (NDRG1). J Biol
Chem. 287:17016–17028. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tu LC, Yan X, Hood L and Lin B: Proteomics
analysis of the interactome of N-myc downstream regulated gene 1
and its interactions with the androgen response program in prostate
cancer cells. Mol Cell Proteomics. 6:575–588. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kachhap SK, Faith D, Qian DZ, et al: The
N-Myc down regulated Gene1 (NDRG1) is a Rab4a effector involved in
vesicular recycling of E-cadherin. PLoS One. 2:e8442007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Klaus A and Birchmeier W: Wnt signalling
and its impact on development and cancer. Nat Rev Cancer.
8:387–398. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Stein S, Thomas EK, Herzog B, et al: NDRG1
is necessary for p53-dependent apoptosis. J Biol Chem.
279:48930–48940. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jung EU, Yoon JH, Lee YJ, et al: Hypoxia
and retinoic acid-inducible NDRG1 expression is responsible for
doxorubicin and retinoic acid resistance in hepatocellular
carcinoma cells. Cancer Lett. 298:9–15. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang AH, Rao JN, Zou T, et al:
p53-dependent NDRG1 expression induces inhibition of intestinal
epithelial cell proliferation but not apoptosis after polyamine
depletion. Am J Physiol Cell Physiol. 293:C379–C389. 2007.
View Article : Google Scholar
|
|
37
|
Kovacevic Z, Sivagurunathan S, Mangs H,
Chikhani S, Zhang D and Richardson DR: The metastasis suppressor,
N-myc downstream regulated gene 1 (NDRG1), upregulates p21 via
p53-independent mechanisms. Carcinogenesis. 32:732–740. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim KR, Moon HE and Kim KW:
Hypoxia-induced angiogenesis in human hepatocellular carcinoma. J
Mol Med (Berl). 80:703–714. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Huang GW, Yang LY and Lu WQ: Expression of
hypoxia-inducible factor 1alpha and vascular endothelial growth
factor in hepatocellular carcinoma: Impact on neovascularization
and survival. World J Gastroenterol. 11:1705–1708. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bristow RG and Hill RP: Hypoxia and
metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev
Cancer. 8:180–192. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
Corn PG and El-Deiry WS: Microarray
analysis of p53-dependent gene expression in response to hypoxia
and DNA damage. Cancer Biol Ther. 6:1858–1866. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Prabhakar NR: Oxygen sensing during
intermittent hypoxia: cellular and molecular mechanisms. J Appl
Physiol. 90:1986–1994. 2001.PubMed/NCBI
|
|
43
|
Bandyopadhyay S, Pai SK, Gross SC, et al:
The Drg-1 gene suppresses tumor metastasis in prostate cancer.
Cancer Res. 63:1731–1736. 2003.PubMed/NCBI
|
